T Seufferlein

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

V Ellenrieder, Sandra F. Hendler, Wolfgang Boeck et al. · PubMed · 2001 · 366 citations

Medicine, Cell Biology, Oncology +17

Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma

Kirsten L. Moek, Walter Fiedler, Jobst C. von Einem et al. · Annals of Oncology · 2018 · 26 citations · Full text

Medicine, Oncology, Pharmacokinetics +9

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma.

Helmut Oettle, Andreas Hilbig, T Seufferlein et al. · Journal of Clinical Oncology · 2011 · 25 citations

Medicine, Oncology, Pharmacology +11

The impact of endoscopic activity on musculoskeletal disorders of high-volume endoscopists in Germany

Niklas Sturm, J. Leukert, Lukas Perkhofer et al. · Scientific Reports · 2022 · 24 citations · Full text

Public Health, Sports Medicine, Ergonomics +16

LBA10 Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer: Final results of the NIFE-trial (AIO-YMO HEP-0315), a randomized phase II study of the AIO biliary tract cancer group

Lukas Perkhofer, Jana K. Striefler, Marianne Sinn et al. · Annals of Oncology · 2021 · 17 citations

Medicine, Oncology, Pharmacology +11